diltiazem has been researched along with Lupus Erythematosus, Systemic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frohwein, T; Li, W; Ong, K | 1 |
| Boorugu, HK; Chrispal, A | 1 |
| Dönmez, O; Durmaz, O | 1 |
| Andersen, LK; Balin, SJ; Davis, MD; Wetter, DA | 1 |
| Lee, FA; Martínez-Osuna, P; McGrath, H | 1 |
| Li, EK; Tam, LS | 1 |
| Amor, B; Kahan, A; Menkes, CJ | 1 |
2 trial(s) available for diltiazem and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus.
Topics: Adult; Aged; Antibodies, Antinuclear; Cross-Over Studies; Diltiazem; DNA; Double-Blind Method; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Photosensitivity Disorders; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy Dosage; Safety; Severity of Illness Index; Treatment Outcome; Ultraviolet Therapy | 1996 |
A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Benzazepines; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Raynaud Disease; Scleroderma, Systemic | 1985 |
5 other study(ies) available for diltiazem and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Cardiac tamponade as an initial presentation for systemic lupus erythematosus.
Topics: Antihypertensive Agents; Cardiac Tamponade; Cardiovascular Agents; Chills; Diltiazem; Dyspnea; Echocardiography; Fever; Humans; Lupus Erythematosus, Systemic; Male; Metoprolol; Middle Aged; Pericardial Effusion; Pericardiocentesis; Treatment Outcome | 2017 |
Calcinosis cutis.
Topics: Adolescent; Aluminum Hydroxide; Antacids; Calcinosis; Calcium Channel Blockers; Dermatomyositis; Diagnosis, Differential; Diltiazem; Female; Humans; Lupus Erythematosus, Systemic; Radiography; Skin Diseases; Treatment Outcome | 2008 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatologic Agents; Diltiazem; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Skin Ulcer; Treatment Outcome | 2010 |
Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Calcinosis; Calcium Channel Blockers; Child; Child, Preschool; Connective Tissue Diseases; Dermatomyositis; Diltiazem; Female; Humans; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Male; Middle Aged; Mitral Valve Prolapse; Mixed Connective Tissue Disease; Myopia; Panniculitis, Lupus Erythematosus; Polymyositis; Retrospective Studies; Scleroderma, Systemic; Skin Diseases; Statistics, Nonparametric; Young Adult | 2012 |
Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cyclophosphamide; Diltiazem; Female; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Prednisone; Vasodilator Agents; Warfarin | 1998 |